Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human bile salt-stimulated lipase

EU orphan designation number: EU/3/04/257   
Active ingredient: Recombinant human bile salt-stimulated lipase
Indication: Treatment of cystic fibrosis
Sponsor: Arexis AB
Drottninggatan 98, SE-111 60 Stockholm, Sverige

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/01/2005 Centralised Orphan - Designation EMEA/OD/023/04 (2005)240 of 26/01/2005
10/02/2012 Other procedure EMEA/OD/023/04